Home
ALK-Abello A/S

ALK-Abello A/S Market Share Analysis for November 2025

Health > Biotechnology and Pharmaceuticals

Domainalk-abello.com

Year Founded1923

Employees1001 - 5000

Annual Revenue$500M - $1B

ALK-Abello A/S

ALK-Abello A/S (including company regionals)

alk-abello.com

See more website traffic and engagement information

ALK-Abello A/S Revenue up to November 2025 is 500M - 1B

revenue generated by ALK-Abello A/S top domains

ALK-Abello A/S top domains revenue over 3 years

Revenue for ALK-Abello A/S top domains

alk-abello.com500M - 1B

See more with Sales Intelligence

Total visits to ALK-Abello A/S's top domains

Understand ALK-Abello A/S market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

alk-abello.com2.4K

See more with Sales Intelligence

Avg. visit duration in ALK-Abello A/S's top domains

Analyze ALK-Abello A/S engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

alk-abello.com00:00:07

See more with Sales Intelligence

Avg. pageviews on ALK-Abello A/S's top domains

See how ALK-Abello A/S keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

alk-abello.com1.52

See more with Sales Intelligence

ALK-Abello A/S top competitors by domain

Top similar sites in November 2025, ranked by their affinity

allergytherapeutics.comCompany NameAllergy TherapeuticsEmployees501 - 1000HQUnited Kingdom, WorthingAnnual revenue$100M - $200MTotal visits2.2KHealth > Biotechnology and Pharmaceuticals

Top technologies used by ALK-Abello A/S

These are the website technologies, by industry, used by ALK-Abello A/S top domains

Widget (4)

reCAPTCHA

Advertising (3)

DoubleClick

Conversion & Analytics (3)

Google Analytics

Audio Video Media (2)

YouTube

More Technologies

7

See all

News & Signals from ALK-Abello A/S

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAllergy Academy partners with Alk-Abello, Inc..Allergy Academy is proud to partner with ALK-Abello to provide an update on current immunotherapy practices in allergy medicine.

NewsAlk-Abello, Inc. launches House Dust Mite and Silver Birch tree pollen sublingual desensitisation immunotherapy vaccines.ALK Abello will be launching their new House Dust Mite (Acarizax) and Silver Birch tree pollen (Itulazax) sublingual desensitisation immunotherapy vaccines (SLIT) in the UK in late 2021.

NewsAlk-Abello, Inc. launched tree pollen immunotherapy Itulazax on Sep 3rd '19.Danish drugmaker ALK-Abello has launched its tree pollen immunotherapy Itulazax in Germany, its first market, following its European approval earlier this year.